Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Key takeaways Retatrutide isn't approved yet and isn't expected to launch in the UK until at least mid-2026 In clinical trials, target doses ranged from 0.5mg to 12mg weekly, with the most common being 4mg, 8mg, 9mg and 12mg Different dosing schedules were tested, with most people starting at 2mg and escalating every 4 weeks The 12mg dose produced the most weight loss (up to 28.7% after 68 weeks) Starting at 2mg rather than 4mg helped reduce side effects during escalation First to know Get an email the day retatrutide launches in the UK
More noticeable results, such as steady energy and better portion control, often take 6-8 weeks of consistent use
When completed in conjunction with the dosage chart, regular follow-ups allow for fine-tuning the treatment based on individual responses and health changes
Arctiko ensures GLP-1 compliance with all major regulations, shielding providers from penalties, reputational damage, and liability
US$ 23.62
US$ 27.10
US$ 24.57
US$ 27.03
